The present application relates to Foskolin induced differentiation treatment of
hepatocellular carcinoma. Specifically, the present application relates to a method and use of
Forskolin for inducing differentiation of human malignant
hepatocellular carcinoma, thereby being applied to the treatment of malignant
solid tumors. The research of the present application shows that after treating
hepatocellular carcinoma cells with exogenous addition of
Forskolin for a period of time, the hepatocellular
carcinoma cells can be effectively induced to differentiate, thereby providing a new
drug for tumor induced differentiation treatment. The purpose of the present application is to provide the use of
Forskolin and its derivatives for anti-hepatoma drugs.